既往脑出血与主要不良心血管事件的关联
该队列研究基于丹麦卒中登记,纳入2005年1月1日至2018年6月30日首次脑出血且存活超过30天的45岁及以上患者8991例,按年龄、性别和脑出血发病日期1:40匹配一般人群对照359185例,随访至2018年12月31日至少6个月。脑出血队列主要不良心血管事件发生率为4.16/100人年,对照为1.35/100人年(aHR 3.13,95%CI 2.97-3.30);缺血性卒中aHR 2.64(95%CI 2.43-2.88),脑出血aHR 23.49(95%CI 21.12-26.13),心肌梗死aHR 1.12(95%CI 0.97-1.29)无统计学显著差异。作者认为脑出血后需关注以降压、抗栓和他汀治疗为主的优化二级预防。
要点
- 既往脑出血患者主要不良心血管事件发生率为4.16/100人年,一般人群为1.35/100人年,aHR 3.13(95%CI 2.97-3.30)。
- 既往脑出血患者再发脑出血发生率为1.44/100人年,一般人群为0.06/100人年,aHR 23.49(95%CI 21.12-26.13)。
- 既往脑出血患者缺血性卒中发生率为1.52/100人年,一般人群为0.56/100人年,aHR 2.64(95%CI 2.43-2.88)。
- 心肌梗死发生率脑出血队列0.52/100人年 vs 一般人群0.48/100人年,aHR 1.12(95%CI 0.97-1.29),未达统计学显著。
- 作者认为脑出血后需关注以降压、抗栓和他汀治疗为主的优化二级预防。
适用人群与场景
- 丹麦卒中登记中2005年1月1日至2018年6月30日首次发生非创伤性(自发性)脑出血、年龄45岁及以上、脑出血后存活超过30天的患者8991例。
- 对照为按年龄、性别和脑出血发病日期1:40匹配的359185例无既往脑出血的一般人群个体。
- 两队列随访至少6个月至2018年12月31日。
研究设计与关键结果
- 研究类型为队列研究,并嵌套病例对照分析;脑出血队列8991例(男性4814例,53.5%;平均[SD]年龄70.7[11.5]岁),对照队列359185例(男性192256例,53.5%;平均[SD]年龄70.7[11.5]岁)。
- 主要不良心血管事件复合终点:脑出血队列4.16/100人年(95%CI 3.96-4.37)vs 对照1.35/100人年(95%CI 1.33-1.36),aHR 3.13(95%CI 2.97-3.30)。
- 缺血性卒中:脑出血队列1.52/100人年(95%CI 1.40-1.65)vs 对照0.56/100人年(95%CI 0.55-0.57),aHR 2.64(95%CI 2.43-2.88)。
- 脑出血:脑出血队列1.44/100人年(95%CI 1.32-1.56)vs 对照0.06/100人年(95%CI 0.06-0.07),aHR 23.49(95%CI 21.12-26.13)。
- 心肌梗死:脑出血队列0.52/100人年(95%CI 0.45-0.60)vs 对照0.48/100人年(95%CI 0.47-0.49),aHR 1.12(95%CI 0.97-1.29),未达统计学显著。
- 嵌套病例对照分析得到的风险估计值与队列分析量级相似。
证据类型、等级与局限
- 证据类型:队列研究(含嵌套病例对照分析),数据来自丹麦卒中登记。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脑出血后需在临床研究和实践中关注以降压、抗栓和他汀治疗为主的优化二级预防。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Patients with stroke due to nontraumatic (spontaneous) intracerebral hemorrhage (ICH) often harbor vascular risk factors and comorbidities, but it is unclear which major adverse cardiovascular events (MACEs) occur more frequently among patients with a prior ICH than the general population.
OBJECTIVE: To evaluate the risk of a MACE for patients with a prior ICH compared with the general population.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study identified 8991 patients with a first ICH in the Danish Stroke Registry from January 1, 2005, to June 30, 2018, who were aged 45 years or older and survived more than 30 days after an ICH. Patients in this ICH cohort were matched 1:40 on age, sex, and ICH-onset date with a comparison cohort of 359 185 individuals from the general population without a prior ICH. Both cohorts were followed up for 6 months or more until December 31, 2018, for outcomes using registry data. Data were analyzed from October 1, 2021, to July 19, 2022.
EXPOSURES: Intracerebral hemorrhage identified by a nationwide clinical database.
MAIN OUTCOMES AND MEASURES: The main outcomes were ICH, ischemic stroke, myocardial infarction, and a composite of MACEs. For each outcome, a case-control study nested within the cohorts was also performed, adjusting for time-varying exposures and potential confounders. Crude absolute event rates per 100 person-years, adjusted hazard ratios (aHRs) and 95% CIs and, in the nested case-control analyses, crude and adjusted odds ratios and 95% CIs were calculated.
RESULTS: The ICH cohort (n = 8991; 4814 men [53.5%]; mean [SD] age, 70.7 [11.5] years) had higher event rates than the comparison cohort (n = 359 185; 192 256 men [53.5%]; mean [SD] age, 70.7 [11.5] years) for MACEs (4.16 [95% CI, 3.96-4.37] per 100 person-years vs 1.35 [95% CI, 1.33-1.36] per 100 person-years; aHR, 3.13 [95% CI, 2.97-3.30]), ischemic stroke (1.52 [95% CI, 1.40-1.65] per 100 person-years vs 0.56 [95% CI, 0.55-0.57] per 100 person-years; aHR, 2.64 [95% CI, 2.43-2.88]), and ICH (1.44 [95% CI, 1.32-1.56] per 100 person-years vs 0.06 [95% CI, 0.06-0.07] per 100 person-years; aHR, 23.49 [95% CI, 21.12-26.13]) but not myocardial infarction (0.52 [95% CI, 0.45-0.60] per 100 person-years vs 0.48 [95% CI, 0.47-0.49] per 100 person-years; aHR, 1.12 [95% CI, 0.97-1.29]). Nested case-control analyses returned risk estimates of similar magnitude as the cohort analyses.
CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that Danish patients with a prior ICH had statistically significantly higher rates of MACEs than the general population, indicating a need for attention to optimal secondary prevention with blood pressure lowering and antithrombotic and statin therapies after an ICH in clinical research and practice.
参考来源
- Gaist D, Hald SM, García Rodríguez LA, et al. Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events. JAMA Netw Open. 2022. PMID: 36190733. doi:10.1001/jamanetworkopen.2022.34215
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。